Abstract #4600: Chk1 inhibitors override the DNA damage checkpoint and enhance anti-tumor activity of irinotecan in p53-deficient tumor xenografts in miceJoe Davide, Weikang Tao, Vicki J. South et al.|Cancer Research|2009Cited by 0